This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Lipomatosis, not elsewhere classified, drug-induced
E4_LIPOMATOSIS_ADVERSE
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
5 |
4. Check minimum number of eventsNone |
5 |
5. Include endpointsNone |
5 |
6. Filter based on genotype QC (FinnGen only) |
5 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- C
- First used in FinnGen datafreeze
- DF5
- Parent code in ICD-10
- E88
- Name in latin
- Lipomatosis non alibi classificata
Similar endpoints
↥List of similar endpoints to
Lipomatosis, not elsewhere classified, drug-induced
based on the number of shared cases.
Similar with more cases:
- Lipomatosis, not elsewhere classified
- Other metabolic disorders
- Metabolic disorders
- Statin medication
- Endocrine, nutritional and metabolic diseases
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (not available in FinRegistry).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 5 | - | - |
| Unadjusted period prevalence (%) | 0.00 | - | - |
| Median age at first event (years) | 52.26 | - | - |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
No data available
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
0
21
0.00
0.84
0.0
2.6
—
—
—
0
0
0
19
0.00
0.82
0.0
5.1
—
—
—
0
0
0
14
0.00
0.50
0.0
1.4
—
—
—
0
0
5
38
+∞
0.24
5.2
4.6
2.2
1.2
mmol/l
—
5
31
5
38
+∞
0.24
5.4
5.2
1.4
1.4
mmol/l
—
5
31
0
12
0.00
0.24
0.0
6.8
—
18.1
—
0
6
5
43
+∞
0.00
26.2
18.3
68.4
71.4
ml/min/173m2
—
5
35
5
43
+∞
0.00
5.6
5.8
6.6
6.1
mmol/l
—
5
38
0
5
0.00
0.00
0.0
9.2
—
—
—
0
0
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
5
42
+∞
0.00
7.4
5.8
2.3
2.4
mmol/l
—
5
34
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
5
45
+∞
-0.00
26.8
20.7
82.2
81.8
umol/l
—
5
45
Mortality – FinRegistry
↥This endpoint is excluded (not available in FinRegistry).
Relationships between endpoints
↥Index endpoint: E4_LIPOMATOSIS_ADVERSE – Lipomatosis, not elsewhere classified, drug-induced
GWS hits: -
This endpoint is excluded (not available in FinRegistry).